YaoGeJu

Company directoryChina company filings

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.

As of 18 November 2026, for the company name Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd. as recorded, the chemical-drug catalogue lists 5 active records with this name as holder; 18 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

19 acceptance records as first applicant, grouped into 11 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Potassium Chloride Granules 1 records · Latest accepted 2026/08/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601567Supplement2026/08/18Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
抗病毒片 · No verified English name 1 records · Latest accepted 2025/02/08

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2500228Supplement2025/02/08Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.; Pan Shi Ju Kang Pharma Co., Ltd. romanizedCDE ↗
Sodium Hyaluronate Eye Drops 1 records · Latest accepted 2025/01/24

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500200Supplement2025/01/24Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Risperidone Orally Disintegrating Tablets 9 records · Latest accepted 2025/01/22

Supplement · 9

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500179Supplement2025/01/22Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
CYHB2500178Supplement2025/01/22Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
CYHB2500177Supplement2025/01/22Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
CYHB2402049Supplement2024/12/04Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
CYHB2402048Supplement2024/12/04Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
CYHB2402047Supplement2024/12/04Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
CYHB2302767Supplement2023/12/23Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
CYHB2302766Supplement2023/12/23Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
CYHB2151002Supplement2021/11/10Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
Levofloxacin Eye Drops 1 records · Latest accepted 2025/01/10

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500066Supplement2025/01/10Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
重酒石酸利斯的明口服溶液 · No verified English name 1 records · Latest accepted 2024/11/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401920Supplement2024/11/18Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.; Shandong Loncom Pharmaceutical Co., Ltd.CDE ↗
Glucosamine Sulfate Capsules 1 records · Latest accepted 2024/08/09

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402565Generic2024/08/09Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
Esmolol Hydrochloride Injection 1 records · Latest accepted 2024/03/08

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400354Supplement2024/03/08Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.; Zhejiang Tian Rui Pharma Co., Ltd. romanizedCDE ↗
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution 1 records · Latest accepted 2024/03/06

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400342Supplement2024/03/06Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.; Shandong Loncom Pharmaceutical Co., Ltd.CDE ↗
Iron Proteinsuccinylate Oral Solution 1 records · Latest accepted 2024/01/06

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400085Generic2024/01/06Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
Roxatidine Acetate Hydrochloride For Injection 1 records · Latest accepted 2024/01/03

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400017Supplement2024/01/03Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.; Jiangsu Jin Si Li Pharma Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

0 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

Catalogue holder records

5 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Glucosamine Sulfate CapsulesJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.国药准字H202559032025/11/12Generic approved under the new chemical-drug registration classificationCDE ↗
Risperidone Orally Disintegrating TabletsJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.国药准字H202472352024/09/30Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Risperidone Orally Disintegrating TabletsJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.国药准字H202472362024/09/30Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Risperidone Orally Disintegrating TabletsJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.国药准字H200602832022/12/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Escitalopram Oxalate TabletsJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.国药准字H201401082020/09/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

18 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
枸橼酸钙 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20240000005A2025/08/22CDE ↗
蛋白琥珀酸铁 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20230000957A2026/03/25CDE ↗
碳酸钙 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190007907A2025/09/18CDE ↗
甘油 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190006487A—CDE ↗
胸腺五肽 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190005514A—CDE ↗
硫酸亚铁 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190003503A2025/08/09CDE ↗
富马酸亚铁 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190003502A2025/08/09CDE ↗
硫酸锌 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190003456A2025/09/02CDE ↗
氧化锌 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190003455A2025/09/18CDE ↗
氧化镁 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190003454A2025/09/18CDE ↗
硫酸铜 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190003453A2025/09/18CDE ↗
氯化钾 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190003452A2025/09/18CDE ↗
重质碳酸镁 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190003391A2026/02/07CDE ↗
阿魏酸钠 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190002649A2025/08/09CDE ↗
瑞香素 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190002637A2025/08/09CDE ↗
唑来膦酸 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190002636A2025/08/09CDE ↗
奥扎格雷 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190002635A—CDE ↗
草酸艾司西酞普兰 · No verified English nameJilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.Y20190001382A2025/08/09CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

5 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Glucosamine Sulfate Capsules CYHB2601688Supplement2026/09/07Hangzhou Min Sheng Health Pharma Co., Ltd. romanized; Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
Bilastine Orally disintegrating Tablets CYHS2602029Generic2026/08/17Shandong Bai Nuo Pharmaceuticals Co., Ltd. romanized; Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
Bilastine Oral Solution CYHS2601558Generic2026/07/01Zhuhai Bei Shan Bio Technology Co., Ltd. romanized; Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
草酸艾司西酞普兰口服溶液 · No verified English name CYHS2504440Generic2025/12/27Shandong Bai Nuo Pharmaceuticals Co., Ltd. romanized; Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗
Bilastine Oral Solution CYHS2502467Generic2025/07/11Zhuhai Bei Shan Bio Technology Co., Ltd. romanized; Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.